C
MIRM icon

Covestor’s Mirum Pharmaceuticals MIRM Stock Holding History

Covestor’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Sell
556
-85
-13% -$8.53K 0.04% 634
2026
Q1 		$59K Sell
641
-639
-50% -$60.1K 0.04% 602
2025
Q4 		$101K Buy
1,280
+1,239
+3,022% +$88.9K 0.05% 574
2025
Q3 		$3K Hold
41
– – ﹤0.01% 1888
2025
Q2 		$2K Sell
41
-9
-18% -$401 ﹤0.01% 1859
2025
Q1 		$2K Sell
50
-21
-30% -$990 ﹤0.01% 1861
2024
Q4 		$3K Buy
71
+56
+373% +$2.33K ﹤0.01% 1812
2024
Q3 		$1K Sell
15
-8
-35% -$319 ﹤0.01% 2035
2024
Q2 		$1K Buy
23
+20
+667% +$524 ﹤0.01% 2052
2024
Q1 		$0 Hold
3
– – ﹤0.01% 2539
2023
Q4 		$0 Sell
3
-1
-25% -$30 ﹤0.01% 2480
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2461
2023
Q2 		$0 Buy
+4
New +$106 ﹤0.01% 2443
2022
Q4 		– Sell
-1
Closed – – 2380
2022
Q3 		$0 Buy
+1
New +$24 ﹤0.01% 2352

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's MIRM Position: Q2 2026 in Review

Covestor reduced its Mirum Pharmaceuticals (MIRM) stake by 13% in Q2 2026, selling an estimated $8.53K and leaving 556 shares worth $65K. The position accounts for 0.04% of the portfolio, ranked #634.

Covestor first reported a position in MIRM in Q3 2022 and has held it in 14 quarters since. The position peaked at $101K in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Covestor held 556 shares of Mirum Pharmaceuticals worth $65K as of Q2 2026.
  • Covestor sold 85 Mirum Pharmaceuticals shares in Q2 2026, an estimated $8.53K.
  • Mirum Pharmaceuticals made up 0.04% of Covestor's portfolio in Q2 2026, its #634 holding.
  • Covestor first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 14 quarters since.
  • Covestor's Mirum Pharmaceuticals position peaked at $101K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.